SRp30c is a Repressor of 3' Splice Site Utilization

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2002 May 25

PMID 12024014

Citations 38

Authors

Martin J Simard

Benoit Chabot

Affiliations

Soon will be listed here.

Abstract

Several intron elements influence exon 7B skipping in the mammalian hnRNP A1 pre-mRNA. We have shown previously that the 38-nucleotide CE9 element located in the intron separating alternative exon 7B from exon 8 can repress the use of a downstream 3' splice site. The ability of CE9 to act on heterologous substrates, combined with the results of competition and gel shift assays, indicates that the activity of CE9 is mediated by a trans-acting factor. UV cross-linking analysis revealed the specific association of a 25-kDa nuclear protein with CE9. Using RNA affinity chromatography, we isolated a 25-kDa protein that binds to CE9 RNA. This protein corresponds to SRp30c. Consistent with a role for SRp30c in the activity of CE9, recombinant SRp30c interacts specifically with CE9 and can promote splicing repression in vitro in a CE9-dependent manner. The closest homologue of SRp30c, ASF/SF2, does not bind to CE9 and does not repress splicing even when the intronic SRp30c binding sites are replaced with high-affinity ASF/SF2 binding sites. Only the first 7 nucleotides of CE9 are sufficient for binding to SRp30c, and mutations that abolish binding also prevent repression. Our results indicate that SRp30c can function as a repressor of 3' splice site utilization and suggest that the SRp30c-CE9 interaction may contribute to the control of hnRNP A1 alternative splicing.

Citing Articles

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression.

Van Goubergen J, Perina M, Handle F, Morales E, Kremer A, Schmidt O Mol Oncol. 2024; 19(2):496-518.

PMID: 39258426 PMC: 11792998. DOI: 10.1002/1878-0261.13728.

hnRNPs: roles in neurodevelopment and implication for brain disorders.

Tilliole P, Fix S, Godin J Front Mol Neurosci. 2024; 17:1411639.

PMID: 39086926 PMC: 11288931. DOI: 10.3389/fnmol.2024.1411639.

Identification of two short peptide motifs from serine/arginine-rich protein ribonucleic acid recognition motif-1 domain acting as splicing regulators.

Jiang T, Wang L, Tang L, Zeb A, Hou Y PeerJ. 2023; 11:e16103.

PMID: 37744237 PMC: 10512959. DOI: 10.7717/peerj.16103.

On the Roles of the Nuclear Non-Coding RNA-Dependent Membrane-Less Organelles in the Cellular Stress Response.

Gavrilova A, Fefilova A, Vishnyakov I, Kuznetsova I, Turoverov K, Uversky V Int J Mol Sci. 2023; 24(9).

PMID: 37175815 PMC: 10179167. DOI: 10.3390/ijms24098108.

Pan-Cancer Analysis Revealed as a New Biomarker for Prognosis and Immunotherapy.

Liu J, Wang Y, Yin J, Yang Y, Geng R, Zhong Z J Oncol. 2022; 2022:3477148.

PMID: 35069733 PMC: 8769850. DOI: 10.1155/2022/3477148.

References

McNally L, McNally M . An RNA splicing enhancer-like sequence is a component of a splicing inhibitor element from Rous sarcoma virus. Mol Cell Biol. 1998; 18(6):3103-11. PMC: 108892. DOI: 10.1128/MCB.18.6.3103. View

Savkur R, Philips A, Cooper T . Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet. 2001; 29(1):40-7. DOI: 10.1038/ng704. View

Hibbert C, Gontarek R, Beemon K . The role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicing. RNA. 1999; 5(3):333-43. PMC: 1369763. DOI: 10.1017/s1355838299981347. View

Nayler O, Stratling W, Bourquin J, Stagljar I, Lindemann L, Jasper H . SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. Nucleic Acids Res. 1998; 26(15):3542-9. PMC: 147731. DOI: 10.1093/nar/26.15.3542. View

Pagani F, Buratti E, Stuani C, Romano M, Zuccato E, Niksic M . Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J Biol Chem. 2000; 275(28):21041-7. DOI: 10.1074/jbc.M910165199. View

Graveley B . Alternative splicing: increasing diversity in the proteomic world. Trends Genet. 2001; 17(2):100-7. DOI: 10.1016/s0168-9525(00)02176-4. View

Graveley B . Sorting out the complexity of SR protein functions. RNA. 2000; 6(9):1197-211. PMC: 1369994. DOI: 10.1017/s1355838200000960. View

Lin C, Patton J . Regulation of alternative 3' splice site selection by constitutive splicing factors. RNA. 1995; 1(3):234-45. PMC: 1369077. View

Blanchette M, Chabot B . Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J. 1999; 18(7):1939-52. PMC: 1171279. DOI: 10.1093/emboj/18.7.1939. View

10.

Kanopka A, Muhlemann O, Akusjarvi G . Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature. 1996; 381(6582):535-8. DOI: 10.1038/381535a0. View

11.

Hanamura A, Caceres J, Mayeda A, Franza Jr B, Krainer A . Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA. 1998; 4(4):430-44. PMC: 1369629. View

12.

Kan J, Green M . Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor. Genes Dev. 1999; 13(4):462-71. PMC: 316470. DOI: 10.1101/gad.13.4.462. View

13.

Eperon I, Ireland D, Smith R, Mayeda A, Krainer A . Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF. EMBO J. 1993; 12(9):3607-17. PMC: 413636. DOI: 10.1002/j.1460-2075.1993.tb06034.x. View

14.

McNally L, McNally M . SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element. J Virol. 1996; 70(2):1163-72. PMC: 189925. DOI: 10.1128/JVI.70.2.1163-1172.1996. View

15.

Lou H, Helfman D, Gagel R, Berget S . Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3'-terminal exon. Mol Cell Biol. 1998; 19(1):78-85. PMC: 83867. DOI: 10.1128/MCB.19.1.78. View

16.

Stoss O, Olbrich M, Hartmann A, Konig H, Memmott J, Andreadis A . The STAR/GSG family protein rSLM-2 regulates the selection of alternative splice sites. J Biol Chem. 2000; 276(12):8665-73. DOI: 10.1074/jbc.M006851200. View

17.

Horabin J, Schedl P . Sex-lethal autoregulation requires multiple cis-acting elements upstream and downstream of the male exon and appears to depend largely on controlling the use of the male exon 5' splice site. Mol Cell Biol. 1993; 13(12):7734-46. PMC: 364845. DOI: 10.1128/mcb.13.12.7734-7746.1993. View

18.

Perez I, McAfee J, Patton J . Multiple RRMs contribute to RNA binding specificity and affinity for polypyrimidine tract binding protein. Biochemistry. 1997; 36(39):11881-90. DOI: 10.1021/bi9711745. View

19.

Yuan Y, Li D, Sun H . PIR1, a novel phosphatase that exhibits high affinity to RNA . ribonucleoprotein complexes. J Biol Chem. 1998; 273(32):20347-53. DOI: 10.1074/jbc.273.32.20347. View

20.

Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View